Koyfin Home > Directory > Health Care > Kura Oncology > Total Equity

Kura Oncology Total Equity Chart (KURA)

Kura Oncology annual/quarterly Total Equity from 2015 to 2020.
  • Kura Oncology Total Equity for the quarter ending June 06, 2020 was $322m a 27.54% increase of 89m year over year
  • Kura Oncology Total Equity for the last 12 months ending June 06, 2020 was $322m a 27.54% increase of 89m year over year
  • Kura Oncology Annual Total Equity for 2019 was $219m a 26.42% increase of 58m from 2018
  • Kura Oncology Annual Total Equity for 2018 was $161m a 50.39% increase of 81m from 2017
  • Kura Oncology Annual Total Equity for 2017 was $80m a 28.78% increase of 23m from 2016
Other Balance Sheet Metrics:
  • Kura Oncology Total Assets for the quarter ending September 09, 2018 was $192m a 49.95% increase of 96m year over year
  • Kura Oncology Other Liabilities for the quarter ending December 12, 2018 was $0m a -59.86% decrease of 0m year over year
View Chart On Koyfin

Quarterly KURA Total Equity Data

06/2020$322m
03/2020$203m
12/2019$219m
09/2019$234m
06/2019$247m
03/2019$150m
12/2018$161m
09/2018$175m
06/2018$112m
03/2018$125m

Annual KURA Total Equity Data

2019$219m
2018$161m
2017$80m
2016$57m
2015$82m
2014$-3m